{
    "organizations": [],
    "uuid": "22e8a5b64ee8d56e644cbe3a8771d9be77d3fb92",
    "author": "",
    "url": "https://www.reuters.com/article/brief-crispr-therapeutics-says-public-of/brief-crispr-therapeutics-says-public-offering-of-5-mln-common-shares-priced-at-22-75-share-idUSASB0BZUS",
    "ord_in_thread": 0,
    "title": "BRIEF-Crispr Therapeutics Says Public Offering Of 5 Mln Common Shares Priced At $22.75/Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 5, 2018 / 12:21 AM / Updated 7 minutes ago BRIEF-Crispr Therapeutics Says Public Offering Of 5 Mln Common Shares Priced At $22.75/Share Reuters Staff \nJan 4 (Reuters) - Crispr Therapeutics AG: \n* CRISPR THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON SHARES \n* SAYS PUBLIC OFFERING OF 5.00 MILLION COMMON SHARES PRICED AT $22.75PER SHARE Source text for Eikon: Further company coverage:",
    "published": "2018-01-05T02:20:00.000+02:00",
    "crawled": "2018-01-05T02:29:28.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "say",
        "public",
        "offering",
        "mln",
        "common",
        "share",
        "priced",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "crispr",
        "therapeutic",
        "ag",
        "crispr",
        "therapeutic",
        "announces",
        "pricing",
        "public",
        "offering",
        "common",
        "share",
        "say",
        "public",
        "offering",
        "million",
        "common",
        "share",
        "priced",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}